Identification of a high-affinity orphanin FQ/nociceptin(1-11) binding site in mouse brain

Synapse

Volumn 34, Issue 3, 1999, Pages 181-186

  Mathis, John P ^a   Goldberg, Ira E ^a   Letchworth, Sharon R ^a   Ryan Moro, Jennifer P ^a   Pasternak, Gavril W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Brain; KOR 3; Nociceptin; Opioid; Orphanin FQ

Indexed keywords

ALPHA NEOENDORPHIN; CYCLAZOCINE; DIPRENORPHINE; DYNORPHIN A DERIVATIVE; FENTANYL; LEVALLORPHAN; NALOXONE BENZOYLHYDRAZONE; NALTRINDOLE; NOCICEPTIN; NOCICEPTIN RECEPTOR; OPIATE; OPIATE RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; BRAIN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING;

ANIMALS; AUTORADIOGRAPHY; BINDING SITES; BRAIN CHEMISTRY; DYNORPHINS; MICE; MICE, INBRED STRAINS; NARCOTICS; OPIOID PEPTIDES; RADIOLIGAND ASSAY; RECEPTORS, OPIOID; VASODILATOR AGENTS;

EID: 0032710425     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(19991201)34:3<181::AID-SYN2>3.0.CO;2-V     Document Type: Article

References (25)

1. Butour JL, Moisand C, Mazarguil H, Mollereau C, Meunier JC. 1997. Recognition and activation of the opioid receptor-like ORL1 receptor by nociceptin, nociceptin analogs and opioids. Eur J Pharmacol 321:97-103.
2. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
3. Chou T-C. 1974. Relationships between inhibition constants and fractional inhibition in enzyme-catalyzed reactions with different numbers of reactants, different reaction mechanisms, and different types and mechanisms of inhibition. Mol Pharmacol 10:235-247.
4. 1 binding assay. Mol Pharmacol 34:308-317.
5. 3 subtype. J Pharmacol Exp Ther 251:461-468.
6. Dooley CT, Houghten RA. 1996. Orphanin FQ: receptor binding and analog structure activity relationships in rat brain. Life Sci 59:PL23-PL29.
7. Hao JX, Wiesenfeld-Hallin Z, Xu XJ. 1997. Lack of cross-tolerance between the antinociceptive effect of intrathecal orphanin FQ and morphine in the rat. Neurosci Lett 223:49-52.
8. King MA, Rossi GC, Chang AH, Williams L, Pasternak GW. 1997. Spinal analgesic activity of orphanin FQ/nociceptin and its fragments. Neurosci Lett 223:113-116.
9. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
10. Luke MC, Hahn EF, Price M, Pasternak GW. 1988. Irreversible opiate agonists and antagonists. V. Hydrazone and acylhydrazone derivatives of naltrexone. Life Sci 43:1249-1256.
11. Mathis JP, Ryan-Moro J, Chang A, Hom JSH, Scheinberg DA, Pasternak GW. 1997. Biochemical evidence for orphanin FQ/ nociceptin receptor heterogeneity in mouse brain. Biochem Biophys Res Commun 230:462-465.
12. Mathis JP, Goldberg IE, Rossi GC, Leventhal L, Pasternak GW. 1998. Antinociceptive analogs of orphanin FQ/nociceptin(1-11). Life Sci 63:L161-L166.
13. 1 receptor. Nature 377:532-535.
14. 3-related opioid receptor using antisense oligodeoxynucleotides. Regul Pept 54:217-218.
15. 3-related opioid receptor. Mol Pharmacol 47:1180-1188.
16. Pan Y-X, Xu J, Ryan-Moro J, Mathis J, Hom JSH, Mei JF, Pasternak GW. 1996. Dissociation of affinity and efficacy in KOR-3 chimeras. FEBS Lett 395:207-210.
17. Pasternak GW, Snyder SH. 1975. Opiate receptor binding: enzymatic treatments and discrimination between agonists and antagonists. Mol Pharmacol 11:735-744.
18. Pasternak GW, Wilson HA, Snyder SH. 1975. Differential effects of protein-modifying reagants on receptor binding of opiate agonists and antagonists. Mol Pharmacol 11:340-351.
19. 3H-naloxone benzoylhydrazone: a reversible kappa and slowly dissociable p opiate. Mol Pharmacol 35:67-74.
20. Reinscheid RK, Nothacker HP, Bourson A, Ardati A, Henningsen RA, Bunzow JR, Grandy DK, Langen H, Monsma FJ, Civelli O. 1995. Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science 270:792-794.
21. Reinscheid RK, Ardati A, Monsma FJ Jr, Civelli O. 1996. Structure-activity relationship studies on the novel neuropeptide orphanin FQ. J Biol Chem 271:14163-14168.
22. Rossi GC, Leventhal L, Pasternak GW. 1996. Naloxone-sensitive orphanin FQ-induced analgesia in mice. Eur J Pharmacol 311:R7-R8.
23. Rossi G, Leventhal L, Boland E, Pasternak GW. 1997. Pharmacological characterization of orphanin FQ/nociceptin and its fragments. J Pharmacol Exp Ther 282:858-865.
24. Tian JH, Xu W, Fang Y, Mogil JS, Grisel JE, Grandy DK, Han JS. 1997. Bidirectional modulatory effect of orphanin FQ on morphine-induced analgesia: antagonism in brain and potentiation in spinal cord of the rat. Br J Pharmacol 120:676-680.
25. Xu XJ, Hao JX, Wiesenfeld-Hallin Z. 1996. Nociceptin or antinociceptin: potent spinal antinociceptive effect of orphanin FQ/nociceptin in the rat. Neuroreport 7:2092-2094.